L. Waele

发表

Renal function in children and adolescents with Duchenne muscular dystrophy

K. Goffin, E. Levtchenko, P. Vermeersch, 2015, Neuromuscular Disorders.

Enzymes: Cytosolic Proteins Calpain‐3, SEPN1, and GNE

V. Straub, R. Barresi, L. Waele, 2013 .

Human iPSC model reveals a central role for NOX4 and oxidative stress in Duchenne cardiomyopathy

K. Desloovere, C. Verfaillie, K. Sipido, 2022, Stem cell reports.

Severe Gastrointestinal Bleeding and Thrombocytopenia in a Child With an Anti-GATA1 Autoantibody

Chantal Thys, Kathleen Freson, R. Vos, 2010, Pediatric Research.

Safety and efficacy of once-daily risdiplam in type 2 and non-ambulant type 3 spinal muscular atrophy (SUNFISH part 2): a phase 3, double-blind, randomised, placebo-controlled trial

G. Comi, S. Corti, E. Mazzone, 2022, The Lancet Neurology.

Serological and cutaneous testing of bovine tuberculosis with the A60 antigen complex from Mycobacterium bovis, strain Calmette-Guérin

Claude Saegerman, C. Saegerman, D. Gilson, 1995 .

Recessive desmin-null muscular dystrophy with central nuclei and mitochondrial abnormalities

Robert W. Taylor, K. Bushby, I. Horrocks, 2013, Acta Neuropathologica.

Ring chromosome 20 syndrome: Electroclinical description of six patients and review of the literature

L. Lagae, K. Jansen, B. Ceulemans, 2012, Epilepsy & Behavior.

Optic Nerve Glioma: General Considerations and a Case Report

J. Kluyskens, L. Waele, P. Naessens, 1981 .

LGP10D10, a Lysosomal Membrane Protein

P. Courtoy, J. Letesson, R. Wattiaux, 1992 .

Safety and efficacy of givinostat in boys with Duchenne muscular dystrophy (EPIDYS): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

G. Acsadi, M. Scoto, E. Finanger, 2024, The Lancet Neurology.

Longitudinal alterations of gait features in growing boys with Duchenne muscular dystrophy

K. Desloovere, A. Van Campenhout, A. Campenhout, 2020 .